Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133.1 USD | -1.39% | -4.96% | +0.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.93% | 13.58B | |
+18.13% | 125B | |
+13.31% | 108B | |
-7.50% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.38% | 16.37B | |
+27.58% | 11.66B | |
+89.29% | 9.17B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- UBS Raises Price Target on Neurocrine Biosciences to $174 From $165, Maintains Buy Rating